Cipher CIP-Tramadol ER Will Not Need Alcohol Interaction Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Cipher no longer needs to complete a Phase I trial to investigate a potential interaction between the once-daily sustained-release pain medication CIP-tramadol ER and high levels of alcohol, the firm said June 15